A Rare Clinical Case of Thyrotoxic Periodic Hypokalemic Paralysis With Unilateral Lower-Limb Weakness
DOI:
https://doi.org/10.14740/jmc5449Keywords:
Thyrotoxic hypokalemic periodic paralysis, Diffuse toxic goiter, Muscle weakness, Transient ischemic attackAbstract
Thyrotoxic hypokalemic periodic paralysis (TPP) is a rare complication of thyrotoxicosis characterized by transient episodes of muscle weakness associated with hypokalemia. The clinical presentation typically includes symmetrical proximal weakness of the lower extremities. Atypical manifestations, especially those mimicking focal neurological disorders, may lead to delayed diagnosis. We describe a case of TPP presenting with recurrent asymmetric muscle weakness, manifesting as transient unilateral lower-limb weakness in a male patient. The episodes occurred predominantly at night and resolved spontaneously without treatment. Due to the unilateral nature of the motor deficit, the condition was initially misinterpreted as transient ischemic attacks, which led to a diagnostic delay of approximately 1 year. Neuroimaging revealed only nonspecific stable white matter lesions, and neurological therapy did not result in clinical improvement. Subsequent endocrinological evaluation demonstrated overt thyrotoxicosis, with elevated free thyroid hormone levels and high titers of thyroid-stimulating hormone receptor antibodies (TRAb), consistent with Graves’ disease. Initiation of antithyroid therapy and beta-blocker treatment led to normalization of thyroid hormone levels and complete resolution of the episodes of muscle weakness. This case illustrates a rare atypical presentation of TPP, manifesting as unilateral lower-limb weakness and mimicking a transient ischemic attack. The report highlights the importance of considering thyrotoxicosis in the differential diagnosis of transient focal neurological deficits, especially in patients with recurrent reversible episodes of muscle weakness.
Published
Issue
Section
License
Copyright (c) 2026 The authors

This work is licensed under a Creative Commons Attribution 4.0 International License.








